Načítá se...
Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer
BACKGROUND: Trastuzumab therapy given in combination with one of several chemotherapy regimens is currently considered the standard of care for the treatment of early-stage, human epidermal growth factor receptor-2 (HER2) -positive breast cancer. The treatment with trastuzumab is due to a significan...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Versita, Warsaw
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4078028/ https://ncbi.nlm.nih.gov/pubmed/24991199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2013-0040 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|